NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $949,520 | -38.9% | 22,880 | -11.4% | 0.00% | -50.0% |
| Q1 2023 | $1,552,875 | -16.0% | 25,821 | +2.5% | 0.01% | -27.3% |
| Q4 2022 | $1,847,833 | +8.4% | 25,192 | +12.3% | 0.01% | 0.0% |
| Q3 2022 | $1,705,000 | +22.7% | 22,438 | +12.2% | 0.01% | +22.2% |
| Q2 2022 | $1,390,000 | -4.7% | 20,000 | +13.6% | 0.01% | +12.5% |
| Q1 2022 | $1,458,000 | +10.4% | 17,600 | 0.0% | 0.01% | +14.3% |
| Q4 2021 | $1,321,000 | -35.4% | 17,600 | 0.0% | 0.01% | -41.7% |
| Q3 2021 | $2,045,000 | -43.8% | 17,600 | +7.3% | 0.01% | -42.9% |
| Q2 2021 | $3,638,000 | +81.1% | 16,400 | +7.9% | 0.02% | +61.5% |
| Q1 2021 | $2,009,000 | -22.5% | 15,200 | +1.5% | 0.01% | -23.5% |
| Q4 2020 | $2,592,000 | – | 14,980 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invus Financial Advisors, LLC | 350,884 | $26,344,000 | 8.01% |
| HARTLINE INVESTMENT CORP/ | 318,109 | $23,884,000 | 3.27% |
| Deep Track Capital, LP | 550,000 | $41,294,000 | 2.92% |
| MORGAN JESS S & CO INC | 43,975 | $3,302,000 | 2.03% |
| Taylor Frigon Capital Management LLC | 46,376 | $3,482,000 | 1.09% |
| Darsana Capital Partners LP | 258,937 | $19,441,000 | 0.90% |
| Private Harbour Investment Management & Counsel, LLC | 13,562 | $1,018,000 | 0.81% |
| Rhenman & Partners Asset Management AB | 120,387 | $9,610,000 | 0.64% |
| COURAGE CAPITAL MANAGEMENT LLC | 10,000 | $751,000 | 0.50% |
| Baillie Gifford | 9,615,168 | $721,906,000 | 0.40% |